Cargando…

Global research output in ‘pharmacovigilance’ during 2010–2020

The rapid spread of Covid-19 pandemic globally has thrust drugs safety into the spotlight and the public is now more aware of the role of healthcare professionals and health regulators. The present study aimed to measure the global research landscape on pharmacovigilance (PV) indexed in Scopus datab...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tyagi, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022
Materias:	Pharmacovigilance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673929/ https://www.ncbi.nlm.nih.gov/pubmed/34972583 http://dx.doi.org/10.1016/j.therap.2021.11.011

Ejemplares similares

A day in the life of a pharmacovigilance case processor
por: Bhangale, Ritesh, et al.
Publicado: (2017)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance
por: Massy, Nathalie, et al.
Publicado: (2023)

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series
por: Chamboux, Morgane, et al.
Publicado: (2023)

Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Pharmacovigilance and assessment of drug safety reports during COVID 19
por: Desai, Mira K
Publicado: (2020)

Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports
por: Salem, M., et al.
Publicado: (2017)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
por: Thota, Prasad, et al.
Publicado: (2018)

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure
por: Tan, Malinda S., et al.
Publicado: (2022)

Causality assessment: A brief insight into practices in pharmaceutical industry
por: Naidu, R. Purushotham
Publicado: (2013)

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval
por: Mendell, Jeanne, et al.
Publicado: (2015)

Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data
por: Steffen, Annika, et al.
Publicado: (2018)

Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020)

A case of intoxication with tea made from Digitalis purpurea
por: Lehmann, Anouk, et al.
Publicado: (2021)

Vaccines and Bell's palsy: A narrative review
por: Bertin, Blandine, et al.
Publicado: (2023)

The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans
por: Dal-Ré, Rafael
Publicado: (2023)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

Pharmacovigilance in China: Evolution and future challenges
por: Song, Haibo, et al.
Publicado: (2022)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance
por: Calderon-Ospina, Carlos-Alberto
Publicado: (2023)

Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis
por: Tachecí, Ilja, et al.
Publicado: (2016)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis
por: Kawashima, Hirotoshi, et al.
Publicado: (2016)

The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
por: Quintero, Gustavo A.
Publicado: (2022)

Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization
por: Täubel, Jӧrg, et al.
Publicado: (2019)

Global Nanotribology Research Output (1996–2010): A Scientometric Analysis
por: Elango, Bakthavachalam, et al.
Publicado: (2013)

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis
por: Marconi, Ettore, et al.
Publicado: (2022)

Impact of risk communication on patient’s safety during the pandemic
por: Zuluaga-Arias, Heyde-Patricia, et al.
Publicado: (2023)

Self-medication and the ‘infodemic’ during mandatory preventive isolation due to the COVID-19 pandemic
por: Gaviria-Mendoza, Andrés, et al.
Publicado: (2022)

Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study
por: Nino-Orrego, Maria Jose, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtmiqjucnmurpikn607k1or3ug